Global and China Cancer Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Platform-based
  • 1.2.3 Instrument-based
• 1.3 Market by Application
  • 1.3.1 Global Cancer Diagnostics Market Share by Application: 2020 VS 2026
  • 1.3.2 Breast Cancer
  • 1.3.3 Lung Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Melanoma
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Diagnostics Market Perspective (2015-2026)
• 2.2 Global Cancer Diagnostics Growth Trends by Regions
  • 2.2.1 Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Diagnostics Players by Market Size
  • 3.1.1 Global Top Cancer Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
• 3.4 Global Cancer Diagnostics Market Concentration Ratio
  • 3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2019
• 3.5 Key Players Cancer Diagnostics Area Served
• 3.6 Key Players Cancer Diagnostics Product Solution and Service
• 3.7 Date of Enter into Cancer Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Diagnostics Breakdown Data by Type (2015-2026)

• 4.1 Global Cancer Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Cancer Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global Cancer Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Diagnostics Market Size (2015-2026)
• 6.2 North America Cancer Diagnostics Market Size by Type (2015-2020)
• 6.3 North America Cancer Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Cancer Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cancer Diagnostics Market Size (2015-2026)
• 7.2 Europe Cancer Diagnostics Market Size by Type (2015-2020)
• 7.3 Europe Cancer Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Cancer Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cancer Diagnostics Market Size (2015-2026)
• 8.2 China Cancer Diagnostics Market Size by Type (2015-2020)
• 8.3 China Cancer Diagnostics Market Size by Application (2015-2020)
• 8.4 China Cancer Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cancer Diagnostics Market Size (2015-2026)
• 9.2 Japan Cancer Diagnostics Market Size by Type (2015-2020)
• 9.3 Japan Cancer Diagnostics Market Size by Application (2015-2020)
• 9.4 Japan Cancer Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cancer Diagnostics Market Size (2015-2026)
• 10.2 Southeast Asia Cancer Diagnostics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cancer Diagnostics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cancer Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Becton, Dickinson and Company
  • 11.1.1 Becton, Dickinson and Company Company Details
  • 11.1.2 Becton, Dickinson and Company Business Overview
  • 11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
  • 11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2015-2020))
  • 11.1.5 Becton, Dickinson and Company Recent Development
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Company Details
  • 11.2.2 GE Healthcare Business Overview
  • 11.2.3 GE Healthcare Cancer Diagnostics Introduction
  • 11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.2.5 GE Healthcare Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Abbott Business Overview
  • 11.3.3 Abbott Cancer Diagnostics Introduction
  • 11.3.4 Abbott Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.3.5 Abbott Recent Development
• 11.4 Roche
  • 11.4.1 Roche Company Details
  • 11.4.2 Roche Business Overview
  • 11.4.3 Roche Cancer Diagnostics Introduction
  • 11.4.4 Roche Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.4.5 Roche Recent Development
• 11.5 Thermo Fisher Scientific
  • 11.5.1 Thermo Fisher Scientific Company Details
  • 11.5.2 Thermo Fisher Scientific Business Overview
  • 11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
  • 11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.5.5 Thermo Fisher Scientific Recent Development
• 11.6 Agilent Technologies
  • 11.6.1 Agilent Technologies Company Details
  • 11.6.2 Agilent Technologies Business Overview
  • 11.6.3 Agilent Technologies Cancer Diagnostics Introduction
  • 11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.6.5 Agilent Technologies Recent Development
• 11.7 Illumina
  • 11.7.1 Illumina Company Details
  • 11.7.2 Illumina Business Overview
  • 11.7.3 Illumina Cancer Diagnostics Introduction
  • 11.7.4 Illumina Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.7.5 Illumina Recent Development
• 11.8 Siemens Healthcare
  • 11.8.1 Siemens Healthcare Company Details
  • 11.8.2 Siemens Healthcare Business Overview
  • 11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
  • 11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.8.5 Siemens Healthcare Recent Development
• 11.9 C.R. Bard
  • 11.9.1 C.R. Bard Company Details
  • 11.9.2 C.R. Bard Business Overview
  • 11.9.3 C.R. Bard Cancer Diagnostics Introduction
  • 11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2015-2020)
  • 11.9.5 C.R. Bard Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer